IMRCs have a good safety profile for administration in vivo
Toxicity
The IMRCs used in this study were the same batch as before, and the detailed karyotyping and in vivo tumorigenicity assays had been described in our previous article.Toxicity test after cell transplantation. The study design, macroscopic observation, histological analysis and representative immunohistochemical staining 8 weeks after cell transplantation. 